Clinical and anamnestic features of patients with gastric polyps
https://doi.org/10.31146/1682-8658-ecg-200-4-71-77
Abstract
Gastric polyps (GP) are a serious clinical problem due to the high prevalence and tendency to malignant transformation with nonspecifi c symptoms. The literature does not describe clinical and anamnestic markers that make it possible to suspect the presence of GP, and tactics for the management of patients with GP are not proposed.
Aim: a study the clinical, anamnestic features of patients with GP, infection with Helicobacter pylori.
Materials and methods: 61 patients with hyperplastic GP (HGP) and 41 with adenomatous GP (AGP) were examined. We conducted a general clinical study of patients’ complaints, also clarifi ed the duration and features of the course of the disease, the association with Helicobacter pylori (HP), endoscopic and ultrasound examination of abdominal organs.
Results: the clinical manifestations of GP are nonspecifi c: non-intense epigastric pain after eating or without connection with food intake, a combination of dyspeptic hyperacid complaints (heartburn) and dyskinetic (nausea, belching with air) character. Symptoms of chronic atrophic gastritis are typical for HGP. There was a high family burden on oncopathology — 21.4% of patients, one in ten had a burdened hereditary history of stomach cancer. In the group of HGP, polyps of other gastrointestinal tract localizations were detected in almost 40% of cases, with AGP in more than half — 25 (61%). Colon polyps and gallbladder polyps were detected in a quarter of patients with AGP. HP infection was detected in GP in more than half of the patients.
Conclusion: patients with chronic atrophic gastritis, cholelithiasis and pathology of the biliary tract, polyps of other localization, burdened with hereditary oncopathology, should be considered at risk of detection of GP. All patients with GP are shown a follow-up examination to detect chronic atrophic gastritis, patology of the biliary tract, polyps and neoplasms.
About the Authors
A. S. Novikova
Tver State Medical University
Russian Federation
Russian Federation
Anastasiya S. Novikova, assistant of the Department of Hospital Therapy and Occupational Diseases
4, Sovetskaya St., Tver, 170100
I. Yu. Kolesnikova
Tver State Medical University
Russian Federation
Russian Federation
Irina Yu. Kolesnikova, MD, PhD, Vice-Rector for Academic and Educational Work; professor of the department of hospital therapy and occupational diseases
Scopus Author ID: 7005390215, Researcher ID ABG-5583–2021
4, Sovetskaya St., Tver, 170100
References
1. Borch K., Skarsgard J., Franzen L. et al. Benign gastric polyps: morphological and functional origin. Dig. Dis. Sci. 2003; 48(7): 1292–1297. doi: 10.1023/a:1024150924457
2. Secemsky B. J., Robinson K. R., Krishnan K., Matkow skyj K. A., Jung B. H. Gastric hyperplastic polyps causing upper gastrointestinal hemorrhage in a young adult. World J Clin Cases. Apr 16, 2013; 1(1): 25–27. doi: 10.12998/wjcc.v1.i1.25.
3. Morais D. J., Yamanaka A., Zeitune J. M.R., Andreollo N. A. Gastric polyps: a retrospectiye analysis of 26, 000 digestive endoscopies. Arq. Gastroenterol. 2007; 44(1). doi: 10.1590/S0004–28032007000100004
4. Abraham S. C., Park S. J., Mugartegui L., et al. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am. J. Pathol. 2002;161:1735–42. doi: 10.1016/S0002–9440(10)64450–1
5. Goddard A. F., Badreldin R., Pritchard D. M., et al. The management of gastric polyps. Gut. 2010;59:1270–76. doi: 10.1136/gut. 2009.182089
6. Gregory Y., Lauwers M. D. Gastric Polyps: Classifi cation and Management. Archives of Pathology and Laboratory Medicine. 2001;132(4): 633–640. doi: 10.5858/2008–132–633-GPCAM
7. Ivashkin V. T., Mayev I. V., Lapina T. L., et al. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018; 28(1):55–70. (In Russ.) doi: 10.22416/1382–4376–2018–28–1–55–70
8. Sheptulin A. A. Kyoto global consensus report on Helicobacter pylorigastritis: summary. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 26(1):59–64. (In Russ.) doi: 10.22416/1382–4376–2016–26–1–59–64
9. Stathopoulos P., Zundt B., Spelsberg F. W., Kolligs L., Diebold J., Goke B., Jungst D. Relation of gallbladder function and Helicobacter pylori infection to gastric mucosa infl ammation in patients with symptomatic cholecystolithiasis. Digestion. 2006; 73(2–3): 69–74. doi: 10.1159/000092746
10. Oba M., Miwa K., Fujimura T., Harada S., Sasaki S., Hattori T. Chemoprevention of glandular stomach carcinogenesis through duodenogastric refl ux in rats by a COX-2 inhibitor. Int J Cancer. 2008, Oct 1; 123 (7): 1491–1498. doi: 10.1002/ijc.23742
11. Oba M., Miwa K., Fujimura T., Harada S., Sasaki S., Hattori T. Chemoprevention of glandular stomach carcinogenesis through duodenogastric refl ux in rats by a COX-2 inhibitor. Int J Cancer. 2008, Oct 1; 123 (7): 1491–1498. doi: 10.1002/ijc.23742
12. Khomyakov V. M., Yermoshina A. D., Pirogov S. S., Ryabov A. B. Stomach cancer risk factors: the modern concept. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017; 27(6):78–86. (In Russ). Doi: 10.22416/1382–4376–2017–27–6–78–86
13. Avanesyan A. A., Chukina O. V., Kokovina Yu.V., Chirkina T. M., Bakulin I. G. Screening for gastric cancer: East and West, features of diagnostic criteria. Experimental and Clinical Gastroenterology. 2020;(9):73–78. (In Russ.) doi: 10.31146/1682–8658-ecg-181–9–73–78
14. Rugge M., Genta R. M. Staging and grading of chronic gastritis. Human Pathology. 2005;36:228–233. doi: 10.1016/j.humpath.2004.12.008
15. Correa P., Blanca Piazuelo M. Th e gastric precancerous cascade. J Clin Exp Pathol. 2013; 3:147. doi: 10.4172/2161–0681.1000147
16. Genta R. M. Defi ning atrophic gastritis and grading gastric atrophy: new challenges beyond the Sydney System. Helicobacter pylori. 1998; 215–223. doi: 10.1007/978–94–011–4882–5–24
17. Carmack S. W., Genta R. M., Graham D. Y., Lauwers G. Y. Management of gastric polyps: a pathologybased guide for gastroenterologists. Nat. Rev. Gastroenterol. Hepatol. 2009; 6:331–341 doi: 10.5858/2008–132–633-GPCAM
18. Abraham S. C., Park S. J., Mugartegui L., et al. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am. J. Pathol. 2002; 161:1735–1742. doi: 10.1016/S0002–9440(10)64450–1
19. Malfertheiner P., Megraud F., O’Morain C.A., et al. Management of Helicobacter pylori infection – the Maastricht IV/ Florence Consensus Report. Gut. 2012;- 61(5):646–664. doi:10.1136/gutjnl-2012–302084
20. Dinis- Ribeiro M., Areia M., de Vries A. C., et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44(1):74–94. doi:10.1055/s-0031–1291491
21. Kolesnikova I. Yu., Novikova A. S. Gastric Polyps and Atrophic Gastritis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(2):27–33. (In Russ.) doi: 10.22416/1382–4376–2021–31–2
Review
For citations:
Novikova A.S., Kolesnikova I.Yu. Clinical and anamnestic features of patients with gastric polyps. Experimental and Clinical Gastroenterology. 2022;(4):71-77. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-200-4-71-77
Views:
365
Email this article 